Market News
AmerisourceBergen (ABC)
AmerisourceBergen's President and Chief Executive Officer, R. David Yos reaffirmed the Company's expectations for fiscal year 2010. "AmerisourceBergen continues to expect diluted earnings per share from continuing operations for fiscal year 2010 to be in a range of $1.89 to $1.98, which represents an increase of 12 percent to 17 percent over the $1.69 in fiscal year 2009," said Yost. "Also unchanged are our key assumptions supporting this diluted earnings per share range, which are: revenue growth of between 7 percent and 8 percent; operating margin expansion in the low to mid single digit basis point range; and free cash flow in the range of $500 million to $575 million, which includes capital expenditures in the $140 million range. Assumptions also include the expected repurchase of approximately $350 million of AmerisourceBergen common shares in fiscal 2010."
AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes.
Mar 5 · 10:09:00 AM · Source: Company Press Release
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb declared a regular quarterly dividend in the amount of $.32 per share payable June 1, 2010 to shareholders of record on May 7, 2010.
At today''s $25.10 stock price the dividend yield is 5.10%.
Mar 5 · 10:03:00 AM
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Merck (MRK)
Today, the Federal Court in Australia dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx.
The Court dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx. Merck and MSD Australia disagree with the limited portions of the Court’s findings that were against MSD Australia and intend to appeal them.
Mar 5 · 9:59:00 AM
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Johnson & Johnson (JNJ)
Reuters.com is reporting that Johnson & Johnson announced that for fiscal 2010, it continues to expect earnings of $4.85 to $4.95 per share. According to Reuters Estimates, analysts on an average are expecting the Company to report earnings per share (EPS) of $4.92 for fiscal 2010.
At today's stock price of about $63.80, with a 2010 EPS of $4.92 that results in a forward PE of about 13. That seems like a flat out steal of a valuation for J&J.
Mar 5 · 9:55:00 AM · Source: Reuters.com
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Anheuser-Busch InBev (BUD)
Anheuser-Busch InBev reported that its profit in 4Q 2009 rose to $1.28 billion from $28 million in the fourth quarter of 2008, which is when the company's $52 billion acquisition of Anheuser-Busch closed.
Its adjusted earnings per share rose to 55 cents from 44 cents -- 8 cents below estimates -- with revenue when combining what was Anheuser-Busch with InBev rising 5% to $9.3 billion.
Mar 4 · 11:30:00 AM · Source: Company Press Release
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
BJ's (BJ)
BJ's today reported net income of $55.1 million, or $1.01 per diluted share, for the fourth quarter ended January 30, 2010. For the full year 2009, the Company reported net income of $132.1 million, or $2.42 per diluted share, compared to $2.28 per diluted share for 2008.
For the fourth quarter ended January 30, 2010, total sales increased by 9.4% to $2.74 billion, and comparable club sales increased by 4.6%, including a contribution from sales of gasoline of 2.3%. For the year ended January 30, 2010, total sales rose by 1.6% to $9.95 billion and comparable club sales decreased by 1.9%, including a negative impact from sales of gasoline of 5.9%. Excluding the impact of gasoline sales, merchandise comparable club sales increased by 4.0% for the full year.
Mar 4 · 11:08:00 AM · Source: Company Press Release
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Walgreen (WAG)
Walgreens is reporting February sales of $5.31 billion, an increase of 3.2 percent from $5.14 billion for the same month in 2009. Sales in comparable stores (those open at least a year) increased 0.4 percent.
February pharmacy sales increased 3.7 percent, while comparable pharmacy sales increased 0.9 percent. Comparable pharmacy sales were negatively affected by 2.4 percentage points due to generic drug introductions in the last 12 months and a lower incidence of flu compared with February 2009. Pharmacy sales accounted for 64.5 percent of total sales for the month.
Mar 4 · 11:01:00 AM · Source: Company Press Release
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Walmart (WMT)
Paidcontent.org is reporting that Walmart is buying online/embedded movie service Vudu. The retailer describes Vudu as a “leading provider of digital technologies and services that enable the delivery of entertainment content directly to broadband high-definition TVs and Blu-ray players” and calls it “revolutionary.” The deal, expected to close in a few weeks, marks Walmart’s latest effort to make online video pay, this time without a connected computer.
Eduardo Castro-Wright, vice chairman for Walmart, explained the move in the announcement: “Combining Vudu’s unique digital technology and service with Walmart’s retail expertise and scale will provide customers with unprecedented access to home entertainment options as they migrate to a digital environment.” Wal-Mart Stores, Inc. (NYSE: WMT) gains access to titles from nearly every major studio and to some 16,000 titles, including, the companies claim, the largest available 1080p VOD library.
Mar 4 · 10:57:00 AM · Source: Paidcontent.org
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Previous · Next
Advertisement